Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Lizcano, JM"'
Autor:
Leary A; Medical Oncology, Institut Gustave Roussy, Villejuif, France., Estévez-García P; Medical Oncology, Hospital Universitario Virgen del Rocío, Sevilla, Spain., Sabatier R; Department of Medical Oncology, Aix-Marseille Univ, Inserm, CNRS, Institut Paoli-Calmettes, 232 Boulevard Sainte Marguerite, Marseille, France., Ray-Coquard I; Medical Oncology, Centre Léon Bérard, Lyon, France., Romeo M; Department of Medical Oncology, Department of Medicine, Institut Català d'Oncologia Badalona Hospital Germans Trias i Pujol, Badalona-Applied Research Group in Oncology, Germans Trias i Pujol Institute, Universitat Autònoma de Barcelona, Badalona, Spain., Barretina-Ginesta P; Medical Oncology Department, Precision Oncology Group (OncoGIR-Pro) Girona Biomedical Research Institute (IDIBGI) and Department of Medical Sciences, Institut Català d'Oncologia (ICO), Medical School University of Girona (UdG), Girona, Spain., Gil-Martin M; Medical Oncology, Catalan Institute of Oncology and IDIBELL, L'Hospitalet del Llobregat, Barcelona, Spain., Garralda E; Medical Oncology Service, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Bosch-Barrera J; Medical Oncology Department, Precision Oncology Group (OncoGIR-Pro) Girona Biomedical Research Institute (IDIBGI) and Department of Medical Sciences, Institut Català d'Oncologia (ICO), Medical School University of Girona (UdG), Girona, Spain., Morán T; Department of Medical Oncology, Department of Medicine, Institut Català d'Oncologia Badalona Hospital Germans Trias i Pujol, Badalona-Applied Research Group in Oncology, Germans Trias i Pujol Institute, Universitat Autònoma de Barcelona, Badalona, Spain., Martin-Martorell P; Medical Oncology, INCLIVA-Hospital Clínico Universitario, Valencia, Spain., Nadal E; Medical Oncology, Catalan Institute of Oncology and IDIBELL, L'Hospitalet del Llobregat, Barcelona, Spain., Gascón P; Medical Oncology Service, Hospital Clínic. Universitat de Barcelona, Barcelona, Spain., Rodon J; Early Drug Development, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA., Lizcano JM; Department of Biochemistry and Molecular Biology, Institut de Neurocièncias, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Barcelona, Spain.; Protein Kinases in Cancer Research, Vall Hebron Institut de Recerca (VHIR), Barcelona, Spain., Muñoz-Guardiola P; Department of Biochemistry and Molecular Biology, Institut de Neurocièncias, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Barcelona, Spain.; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain., Fierro-Durán G; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain., Pedrós-Gámez O; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain., Pérez-Montoyo H; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain., Yeste-Velasco M; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain., Cortal M; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain., Pérez-Campos A; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain., Alfon J; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain., Domenech C; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain. carles.domenech@abilitypharma.com., Pérez-Fidalgo A; Medical Oncology, INCLIVA-Hospital Clínico Universitario, Valencia, Spain., Oaknin A; Medical Oncology Service, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Publikováno v:
BMC cancer [BMC Cancer] 2024 Jul 29; Vol. 24 (1), pp. 911. Date of Electronic Publication: 2024 Jul 29.
Autor:
Leary A; Medical Oncology, Institut Gustave Roussy, Villejuif, France., Estévez-García P; Medical Oncology, Hospital Universitario Virgen del Rocío, Sevilla, Spain., Sabatier R; Department of Medical Oncology, Aix-Marseille Univ, Inserm, CNRS, Institut Paoli-Calmettes, 232 Boulevard Sainte Marguerite, Marseille, France., Ray-Coquard I; Medical Oncology, Centre Léon Bérard, Lyon, France., Romeo M; Department of Medical Oncology, Department of Medicine, Institut Català d'Oncologia Badalona Hospital Germans Trias i Pujol, Badalona-Applied Research Group in Oncology, Germans Trias i Pujol Institute, Universitat Autònoma de Barcelona, Badalona, Spain., Barretina-Ginesta P; Medical Oncology Department, Precision Oncology Group (OncoGIR-Pro) Girona Biomedical Research Institute (IDIBGI) and Department of Medical Sciences, Institut Català d'Oncologia (ICO), Medical School University of Girona (UdG), Girona, Spain., Gil-Martin M; Medical Oncology, Catalan Institute of Oncology and IDIBELL, L'Hospitalet del Llobregat, Barcelona, Spain., Garralda E; Medical Oncology Service, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Bosch-Barrera J; Medical Oncology Department, Precision Oncology Group (OncoGIR-Pro) Girona Biomedical Research Institute (IDIBGI) and Department of Medical Sciences, Institut Català d'Oncologia (ICO), Medical School University of Girona (UdG), Girona, Spain., Morán T; Department of Medical Oncology, Department of Medicine, Institut Català d'Oncologia Badalona Hospital Germans Trias i Pujol, Badalona-Applied Research Group in Oncology, Germans Trias i Pujol Institute, Universitat Autònoma de Barcelona, Badalona, Spain., Martin-Martorell P; Medical Oncology, INCLIVA-Hospital Clínico Universitario, Valencia, Spain., Nadal E; Medical Oncology, Catalan Institute of Oncology and IDIBELL, L'Hospitalet del Llobregat, Barcelona, Spain., Gascón P; Medical Oncology Service, Hospital Clínic. Universitat de Barcelona, Barcelona, Spain., Rodon J; Early Drug Development, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA., Lizcano JM; Department of Biochemistry and Molecular Biology, Institut de Neurocièncias, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Barcelona, Spain.; Protein Kinases in Cancer Research, Vall Hebron Institut de Recerca (VHIR), Barcelona, Spain., Muñoz-Guardiola P; Department of Biochemistry and Molecular Biology, Institut de Neurocièncias, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Barcelona, Spain.; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain., Fierro-Durán G; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain., Pedrós-Gámez O; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain., Pérez-Montoyo H; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain., Yeste-Velasco M; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain., Cortal M; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain., Pérez-Campos A; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain., Alfon J; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain., Domenech C; Research and Development, Ability Pharmaceuticals, Cerdanyola del Vallès, Barcelona, Spain. carles.domenech@abilitypharma.com., Pérez-Fidalgo A; Medical Oncology, INCLIVA-Hospital Clínico Universitario, Valencia, Spain., Oaknin A; Medical Oncology Service, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Publikováno v:
BMC cancer [BMC Cancer] 2024 Jul 22; Vol. 24 (1), pp. 876. Date of Electronic Publication: 2024 Jul 22.
Autor:
Gallo-Oller G; Childhood Cancer and Blood Disorders, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain., Pons G; Childhood Cancer and Blood Disorders, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain., Sansa-Girona J; Childhood Cancer and Blood Disorders, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain., Navarro N; Childhood Cancer and Blood Disorders, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain., Zarzosa P; Childhood Cancer and Blood Disorders, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain., García-Gilabert L; Childhood Cancer and Blood Disorders, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain., Cabré-Fernandez P; Childhood Cancer and Blood Disorders, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain., Guillén Burrieza G; Paediatric Surgery Department, Vall d'Hebron University Hospital, Barcelona, Spain., Valero-Arrese L; Paediatric Oncology and Haematology Department, Vall d'Hebron University Hospital, Barcelona, Spain., Segura MF; Childhood Cancer and Blood Disorders, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain., Lizcano JM; Departament de Bioquímica i Biologia Molecular and Institut de Neurociències. Facultat de Medicina, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.; Protein Kinases in Cancer Research. Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain., Sánchez de Toledo J; Childhood Cancer and Blood Disorders, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain., Moreno L; Paediatric Oncology and Haematology Department, Vall d'Hebron University Hospital, Barcelona, Spain.; Departament de Pediatria, Facultat de Medicina, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain., Gallego S; Paediatric Oncology and Haematology Department, Vall d'Hebron University Hospital, Barcelona, Spain.; Departament de Pediatria, Facultat de Medicina, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain., Roma J; Childhood Cancer and Blood Disorders, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain. josep.roma@vhir.org.
Publikováno v:
Experimental hematology & oncology [Exp Hematol Oncol] 2024 Apr 05; Vol. 13 (1), pp. 38. Date of Electronic Publication: 2024 Apr 05.